Skip to main content
HR 1068 104th Congress House Health Kidney diseases Medicare

To direct the Secretary of Health and Human Services to conduct a demonstration project under which payment shall be made under the medicare program for renal disease management services furnished to individuals at risk for end stage renal disease to accurately assess whether those management services can prevent the progression of renal disease to renal failure and thereby delay the onset of dialysis and cause savings for the medicare program.

Introduced: February 27, 1995 See on congress.gov
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 3, 1995
Referred to the Subcommittee on Health and Environment.
Mar 1, 1995
Referred to the Subcommittee on Health.
Feb 27, 1995
Referred to the Committee on Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 27, 1995
Sponsor introductory remarks on measure. (CR E442)
Feb 27, 1995
Introduced in House
 Plain-English summary Congressional Research Service

Requires the Secretary of Health and Human Services to conduct a three-year demonstration project at two sites under which payments shall be made under the Medicare program for renal disease management services furnished to eligible individuals in order to accurately assess whether those management services can prevent the progression of renal disease to renal failure and thereby delay the onset of dialysis and cause savings for the program.

Describes eligible individuals and renal disease management services for purposes of this Act.

Sets forth criteria for determining payment for renal disease management services covered, and not covered, under Medicare.

Requires the Secretary to enter into a contract with an entity to monitor the project and to assess and make public the extent to which: (1) the implementation of renal disease management services produces increased job retention, preservation of meaningful and taxable income, or improvement in the quality of life; (2) such services affect the patient's functional outcome and or natural history of their kidney disease as compared to a control group; and (3) the implementation of such services has delayed the progression of renal disease and, therefore, the onset of dialysis.

What's happening now March 3, 1995

Referred to the Subcommittee on Health and Environment.

 Committees of jurisdiction 4